将人工智能应用于癌症免疫疗法。
关键词: AI, artificial intelligence Artificial intelligence CT, computed tomography CTLA-4, cytotoxic T lymphocyte-associated antigen 4 Cancer immunotherapy DL, deep learning Diagnostics ICB, immune checkpoint blockade MHC-I, major histocompatibility complex class I ML, machine learning MMR, mismatch repair MRI, magnetic resonance imaging Machine learning PD-1, programmed cell death protein 1 PD-L1, PD-1 ligand1 TNBC, triple-negative breast cancer US, ultrasonography irAEs, immune-related adverse events AI, artificial intelligence Artificial intelligence CT, computed tomography CTLA-4, cytotoxic T lymphocyte-associated antigen 4 Cancer immunotherapy DL, deep learning Diagnostics ICB, immune checkpoint blockade MHC-I, major histocompatibility complex class I ML, machine learning MMR, mismatch repair MRI, magnetic resonance imaging Machine learning PD-1, programmed cell death protein 1 PD-L1, PD-1 ligand1 TNBC, triple-negative breast cancer US, ultrasonography irAEs, immune-related adverse events
来 源:
DOI:10.1016/j.apsb.2021.02.007
PDF(Sci-hub)
PDF(Pubmed)